KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $368.7 million.

  • Medpace Holdings' Accumulated Expenses rose 2016.44% to $368.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $368.7 million, marking a year-over-year increase of 2016.44%. This contributed to the annual value of $307.8 million for FY2024, which is 506.76% up from last year.
  • Latest data reveals that Medpace Holdings reported Accumulated Expenses of $368.7 million as of Q3 2025, which was up 2016.44% from $323.5 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Accumulated Expenses ranged from a high of $368.7 million in Q3 2025 and a low of $123.6 million during Q1 2021
  • Moreover, its 5-year median value for Accumulated Expenses was $231.9 million (2023), whereas its average is $235.6 million.
  • As far as peak fluctuations go, Medpace Holdings' Accumulated Expenses skyrocketed by 4166.78% in 2021, and later skyrocketed by 506.76% in 2024.
  • Over the past 5 years, Medpace Holdings' Accumulated Expenses (Quarter) stood at $159.3 million in 2021, then surged by 31.92% to $210.1 million in 2022, then surged by 39.42% to $293.0 million in 2023, then rose by 5.07% to $307.8 million in 2024, then increased by 19.8% to $368.7 million in 2025.
  • Its last three reported values are $368.7 million in Q3 2025, $323.5 million for Q2 2025, and $286.1 million during Q1 2025.